# A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

> **NCT07003100** · — · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Recurrent Mycosis Fungoides
- Recurrent Sezary Syndrome
- Refractory Mycosis Fungoides
- Refractory Sezary Syndrome
- Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
- Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
- Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
- Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
- Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT07003100
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-06
- **Primary completion:** 2026-10-19
- **Final completion:** 2026-10-19
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07003100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07003100, "A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07003100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*